EGRX DCF Valuation - Eagle Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.2 USD -20% Market Closed

Market Cap: $2.6m

	Eagle Pharmaceuticals Inc NASDAQ:EGRX	US
	BML Inc TSE:4694	JP
	Home Bancorp Inc NASDAQ:HBCP	US
	General Interface Solution (GIS) Holding Ltd TWSE:6456	TW
	Comforia Residential Reit Inc TSE:3282	JP
	Arovella Therapeutics Ltd ASX:ALA	AU
S	Swadeshi Polytex Ltd BSE:503816	IN
	Anpario PLC LSE:ANP	UK
	CTEK AB (publ) STO:CTEK	SE
	Select Medical Holdings Corp NYSE:SEM	US
	State Trading Corporation of India Ltd NSE:STCINDIA	IN
T	TFE Co Ltd KOSDAQ:425420	KR
A	Attica Holdings SA XBER:AAE1	GR
D	Downstream SA WSE:DOW	PL
	Media Chinese International Ltd HKEX:685	HK

EGRX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.